IBM Pushes Enterprise Cloud Computing

Company launches new software, services, clients, and partnerships

February 11, 2009

1 Min Read
NetworkComputing logo in a gray background | NetworkComputing

ARMONK, N.Y., and LAS VEGAS and SHANGHAI, China -- At events around the world, IBM (NYSE: IBM) will reveal a series of new products, services, clients and partnerships for its Blue Cloud initiative through which IBM is collaborating to develop and test integrated cloud solutions for businesses.

New IBM software manages and secures cloud computing environments

IBM showcases the first live demonstration of a global “overflow cloud” – IBM and Juniper Networks to install hybrid cloud capabilities across IBM’s worldwide Cloud Labs for customer engagements

Built from extensive experience working with hundreds of clients in its 13 worldwide cloud centers, IBM today has a cross-company portfolio of cloud computing offerings for business, such as server capacity on demand, online data protection, and Lotus e-mail and collaboration software. Analyst firm IDC predicts that cloud computing services will represent a $42 billion market by 2012;[1] IBM is today announcing five new clients using its cloud computing technologies and services.

Indigo BioSystems, Inc. a privately held company offering data management and automated analysis solutions for life science researchers with a focus on the pharmaceutical industry, has recently selected IBM 's Compute on Demand cloud services to provide clients with a highly secure, scalable and compliant environment for data exchange. As the company works to expand its presence across multiple geographies, IBM is offering resources for building and delivering high performance solutions based on a globally accessible cloud environment.“We are pleased with our collaboration with IBM because in addition to meeting our clients’ requirements for a scalable and globally accessible platform for data exchange, IBM’s cloud services add the security and regulatory compliance needed to satisfy the pharmaceutical industry,” said Randall K Julian, Jr. Ph.D., President, Indigo BioSystems, Inc.

IBM Corp.

SUBSCRIBE TO OUR NEWSLETTER
Stay informed! Sign up to get expert advice and insight delivered direct to your inbox

You May Also Like


More Insights